Dec 16, 2024, 13:20
Predicting the effectiveness of CAR T-cell therapy in children with leukemia (B-ALL) – The Princess Máxima Center for Pediatric Oncology
The Princess Máxima Center for Pediatric Oncology posted on LinkedIn:
“Two new studies start thanks to funding from KWF Kankerbestrijding (Dutch Cancer Society) – Alpe d’HuZes. Ruben van Boxtel, Maarten Geurts and Friso Calkoen want to be able to predict the effectiveness of CAR T-cell therapy in children with leukemia (B-ALL). And Jorik van Rijn aims to find leads for the development of CAR T cell therapy for children with T-lymphoblastic leukemia or lymphoma (T-LBLL).”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 16, 2024, 13:11
Dec 16, 2024, 13:09
Dec 16, 2024, 13:01
Dec 16, 2024, 12:56
Dec 16, 2024, 12:23